Received Mar 25, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | 1 | Unknown | PO / MO |
The patient administered Vivotif with cold water and five minutes after started eating a meal; Non-significant follow-up was downloaded from VAERS on 09-May-2025 included new reference number. Case reference number US-BN-2024-002686 is a spontaneous case initially received from a pharmacist via Med Communications (reference number: USBAV24-2819) on 24-Oct-2024 and concerns a female patient of unknown age. The patient's medical history and concomitant medication details were not provided. On an unspecified date, the patient took the first dose of Vivotif (batch number: unknown), at unknown dose, orally, for indication reported as pre travel. As reported the patient administered Vivotif with cold water and five minutes after started eating a meal (explicitly coded as 'product administration error'). At the time of the initial report, it was unknown if the patient experienced any adverse event due to Vivotif. Non-significant follow-up was downloaded from VAERS on 09-May-2025 included new reference number. Administrative update performed within the case: Worldwide Unique Case Identification Number (WWID) updated from US-20241024-5c9941 to US-BAVARIAN NORDIC A/S-US-BN-2024-002686, in accordance with ICH guidance on WWID formatting.; Reporter's Comments: A female patient of unknown age took the first dose of Vivotif, at unknown dose, orally, for indication reported as pre travel. Reportedly the patient administered Vivotif with cold water and five minutes after started eating a meal which is considered as product administration error. Product administration error is considered listed per company convention. At this point it was unknown if the patient experienced any adverse event due to Vivotif. The patient's medical history and concomitant medication details were not provided. Causality is assessed as not related to suspect product but to human factor. The case is non-serious.; Sender's Comments: A female patient of unknown age took the first dose of Vivotif, at unknown dose, orally, for indication reported as pre travel. Reportedly the patient administered Vivotif with cold water and five minutes after started eating a meal which is considered as product administration error. Product administration error is considered listed per company convention. At this point it was unknown if the patient experienced any adverse event due to Vivotif. The patient's medical history and concomitant medication details were not provided. Causality is assessed as not related to suspect product but to human factor. The case is non-serious.
Comments: None